Log in

Relevant bibliographies by topics / MI treatment / Journal articles

To see the other types of publications on this topic, follow the link: MI treatment.

Journal articles on the topic 'MI treatment'

Author: Grafiati

Published: 7 June 2025

Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'MI treatment.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Butler, John. "Treatment Of Acute Mi." Postgraduate Medicine 106, no. 6 (1999): 57–84. http://dx.doi.org/10.3810/pgm.1999.11.773.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Stephenson, J. "Preventing MI Treatment Delays." JAMA: The Journal of the American Medical Association 279, no. 19 (1998): 1513—c—1513. http://dx.doi.org/10.1001/jama.279.19.1513-c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Stephenson, Joan. "Preventing MI Treatment Delays." JAMA 279, no. 19 (1998): 1513. http://dx.doi.org/10.1001/jama.279.19.1513-jha80003-4-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Naar-King, Sylvie. "Motivational Interviewing in Adolescent Treatment." Canadian Journal of Psychiatry 56, no. 11 (2011): 651–57. http://dx.doi.org/10.1177/070674371105601103.

Full text

Abstract:

This paper briefly reviews the research literature on motivational interviewing (MI) and behaviour change in adolescents and then discusses the implications of adolescent cognitive and social–emotional developmental processes for the relational and technical components of MI. Research suggests that MI is efficacious in improving substance use in adolescents. Research has been slower to emerge in other behaviours, but available randomized controlled trials suggest that MI has great promise for improving mental and physical health outcomes in this developmental period. The relational and technic

APA, Harvard, Vancouver, ISO, and other styles

5

Zerwic, Julie Johnson, and Catherine J. Ryan. "Delays in Seeking MI Treatment." AJN, American Journal of Nursing 104, no. 1 (2004): 81–83. http://dx.doi.org/10.1097/00000446-200401000-00027.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Westra, Henny A., Adi Aviram, and Faye K. Doell. "Extending Motivational Interviewing to the Treatment of Major Mental Health Problems: Current Directions and Evidence." Canadian Journal of Psychiatry 56, no. 11 (2011): 643–50. http://dx.doi.org/10.1177/070674371105601102.

Full text

Abstract:

Motivational interviewing (MI) was originally developed for the treatment of substance abuse but is rapidly expanding to other major mental health populations beyond addictions. This brief review considers the use of MI and related motivational enhancement therapies (METs) in the treatment of anxiety, depression, and eating disorders, and concurrent psychosis and substance use disorders. MI-MET has been added and (or) integrated into treatment for these problems in a wide variety of ways, most commonly as a pretreatment to other therapies (psychosocial treatments and pharmacotherapy) or integr

APA, Harvard, Vancouver, ISO, and other styles

7

Bowen, R., Y. Mahmood, A. Milani, and M. Baetz. "Change in mood instability (MI) with time and treatment." European Psychiatry 26, S2 (2011): 193. http://dx.doi.org/10.1016/s0924-9338(11)71903-4.

Full text

Abstract:

IntroductionThe literature indicates that most patients with Major Depression mention sudden short “mood swings” (MI) when asked. MI is known to be distressing but little is known about the treatment.ObjectivesTo determine whether MI changes with community treatment of depression.AimTo study changes in MI with 3-6 months of treatment for depression in patients with Major Depression and complaints of MI.Methods34 patients with Major Depression and complaints of “mood swings” were recruited from 4 psychiatric practices. They were interviewed with the MINI diagnostic interview and the Mood Disord

APA, Harvard, Vancouver, ISO, and other styles

8

&NA;. "Factors affecting treatment delay in MI." Inpharma Weekly &NA;, no. 1043 (1996): 17. http://dx.doi.org/10.2165/00128413-199610430-00033.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

&NA;. "Invasive vs conservative treatment post-MI." Inpharma Weekly &NA;, no. 1105 (1997): 11. http://dx.doi.org/10.2165/00128413-199711050-00021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

&NA;. "Advances in the treatment of MI." Inpharma Weekly &NA;, no. 784 (1991): 12–13. http://dx.doi.org/10.2165/00128413-199107840-00036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

&NA;. "STEMI Reduces MI Time to Treatment." Emergency Medicine News 28, no. 8 (2006): 40. http://dx.doi.org/10.1097/00132981-200608000-00046.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Motova, Anna V., Viktoriya N. Karetnikova, Anastasiya V. Osokina, et al. "TYPE 2 MYOCARDIAL INFARCTION: MODERN DIAGNOSTIC TECHNIQUES AND TREATMENT." Complex Issues of Cardiovascular Diseases 12, no. 4 (2023): 7–19. http://dx.doi.org/10.17802/2306-1278-2023-12-4-7-19.

Full text

Abstract:

HighlightsPatients with type 2 myocardial infarction have a more favorable course of the disease in the long-term postinfarction period compared with patients with type 1 myocardial infarction. We have determined the differences in clinical and anamnestic characteristics of patients with type 1 and type 2 MI. AbstractAim. To determine the prevalence of patients with type 2 myocardial infarction (MI) and their features in clinical practice.Methods. The prospective study involved 204 patients with acute coronary syndrome (ACS). The inclusion criteria were as follows: diagnosed ACS at admission f

APA, Harvard, Vancouver, ISO, and other styles

13

Carrico, C. "A Sewage Treatment." Molecular Interventions 7, no. 4 (2007): 224–25. http://dx.doi.org/10.1124/mi.7.4.9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Pan, Xianying, Devashish Verma, Jiayin Zhang, Yifan Zhang, and Xiaomei Ma. "Factors associated with the occurrence of myocardial infarction in patients treated for melanoma." Journal of Clinical Oncology 40, no. 16_suppl (2022): 10562. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.10562.

Full text

Abstract:

10562 Background: Treatments for melanoma increasingly involve the use of immune checkpoint inhibitors (ICIs), which are associated with cardiac toxicities. Our study aims to examine predictors of myocardial infarction (MI) in melanoma patients receiving treatment. Methods: The United Healthcare (Optum Clinformatics) Closed Claims + Lab Results Database (01/2007 – 03/2021) was used to examine factors potentially associated with the occurrence of hospitalized MI in melanoma patients. Adult patients were included if they: 1) had ≥12 months of continuous insurance coverage at baseline; 2) had ≥2

APA, Harvard, Vancouver, ISO, and other styles

15

Atkinson, Cathy, and Kevin Woods. "Establishing Theoretical Stability and Treatment Integrity for Motivational Interviewing." Behavioural and Cognitive Psychotherapy 45, no. 4 (2017): 337–50. http://dx.doi.org/10.1017/s1352465817000145.

Full text

Abstract:

Background: There is increasing evidence claiming the effectiveness of motivational interviewing (MI) in promoting behavioural change. However, ongoing changes to MI theory and practice have implications for its transferability, accessibility and for the validity of previous findings. Lack of practice consistency may make its effectiveness difficult to evaluate. Aims: This paper explores the complexity of MI and issues in the development of evidence-based practice in delivery, before describing issues related to practitioner application. Method: Theoretical and practice developments over the l

APA, Harvard, Vancouver, ISO, and other styles

16

Nordendahl, E., B. Kjellström, C. M. Fored, et al. "Invasive Dental Treatment and Risk for a First Myocardial Infarction." Journal of Dental Research 97, no. 10 (2018): 1100–1105. http://dx.doi.org/10.1177/0022034518767834.

Full text

Abstract:

Invasive dental treatment is suggested to be associated with an increased risk for the development of cardiovascular events. We tested the hypothesis that the incidence of a first myocardial infarction (MI) within 4 wk after invasive dental treatments is increased. A registry-based case-control study within nationwide health care and population registries in Sweden was performed. The case patients included 51,880 individuals with a first fatal or nonfatal MI between January 2011 and December 2013. For each case, 5 control subjects, free from prior MI and matched for age, sex, and geographic ar

APA, Harvard, Vancouver, ISO, and other styles

17

Güzel, Nizamettin, Özgür Günal, and Mustafa Usanmaz. "Short-Term or Long-Term Treatment in Osteomyelitis?" Flora the Journal of Infectious Diseases and Clinical Microbiology 28, no. 2 (2023): 283–84. http://dx.doi.org/10.5578/flora.20239927.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

McCoy, Sara S., Cynthia S. Crowson, Hilal Maradit-Kremers, et al. "Longterm Outcomes and Treatment After Myocardial Infarction in Patients with Rheumatoid Arthritis." Journal of Rheumatology 40, no. 5 (2013): 605–10. http://dx.doi.org/10.3899/jrheum.120941.

Full text

Abstract:

Objective.To investigate the risk profiles, treatment, and outcomes of patients with rheumatoid arthritis (RA) with myocardial infarction (MI) and matched MI patients without RA.Methods.We used a population-based cohort of Olmsted County, Minnesota, residents with MI from the period 1979–2009. We identified 77 patients who fulfilled the American College of Rheumatology 1987 criteria for RA and 154 MI patients without RA matched for age, sex, and calendar year. Data collection from medical records included RA and MI characteristics, antirheumatic and cardioprotective medications, reperfusion th

APA, Harvard, Vancouver, ISO, and other styles

19

Strik, Jacqueline J. M. H., Adriaan Honig, Edwin Klinkenberg, Jeanette Dijkstra, and Jelle Jolles. "Cognitive performance following fluoxetine treatment in depressed patients post myocardial infarction." Acta Neuropsychiatrica 18, no. 1 (2006): 1–6. http://dx.doi.org/10.1111/j.0924-2708.2006.00110.x.

Full text

Abstract:

Background:As depression is a considerable risk factor for an unfavourable course of myocardial infarction (MI), antidepressant treatment of post-MI depression and, inherent to MI status, polypharmacy has become an important issue.Objective:The present study is the first to evaluate cognitive side effects of fluoxetine, as part of a placebo-controlled double-blind trial, in patients with post-first MI depression.Methods:Cognitive performance of 54 depressed patients post first-MI, treated with fluoxetine or placebo was compared. Cognitive performance was tested before and after 9 weeks of trea

APA, Harvard, Vancouver, ISO, and other styles

20

Dean, S., E. Britt, E. Bell, J. Stanley, and S. Collings. "Motivational interviewing to enhance adolescent mental health treatment engagement: a randomized clinical trial." Psychological Medicine 46, no. 9 (2016): 1961–69. http://dx.doi.org/10.1017/s0033291716000568.

Full text

Abstract:

BackgroundThe prevalence of anxiety and mood disorders in adolescents is a growing public health concern worldwide. Given the high rates of drop-out and limited resources available in psychiatric settings, the importance of engaging adolescents in evidence-based treatments cannot be understated. The aim of the study was to determine the efficacy of motivational interviewing (MI), as a brief pre-treatment intervention, to enhance treatment engagement in a standard therapy setting (group cognitive behavioral therapy; gCBT) for adolescents with anxiety and mood disorders.MethodNinety-six adolesce

APA, Harvard, Vancouver, ISO, and other styles

21

Wang, Yu, Meiping Wu, and Haidong Guo. "Modified mRNA as a Treatment for Myocardial Infarction." International Journal of Molecular Sciences 24, no. 5 (2023): 4737. http://dx.doi.org/10.3390/ijms24054737.

Full text

Abstract:

Myocardial infarction (MI) is a severe disease with high mortality worldwide. However, regenerative approaches remain limited and with poor efficacy. The major difficulty during MI is the substantial loss of cardiomyocytes (CMs) with limited capacity to regenerate. As a result, for decades, researchers have been engaged in developing useful therapies for myocardial regeneration. Gene therapy is an emerging approach for promoting myocardial regeneration. Modified mRNA (modRNA) is a highly potential delivery vector for gene transfer with its properties of efficiency, non-immunogenicity, transien

APA, Harvard, Vancouver, ISO, and other styles

22

&NA;. "Possible to avoid needless treatment for MI?" Inpharma Weekly &NA;, no. 950 (1994): 7. http://dx.doi.org/10.2165/00128413-199409500-00012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

&NA;. "Post-MI ??-blocker treatment in the elderly." Inpharma Weekly &NA;, no. 1000 (1995): 14. http://dx.doi.org/10.2165/00128413-199510000-00032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Ratner, David, Elyakim Eshel, and Karola Vigdor. "Ambulatory treatment of patients with suspected MI." Drug Intelligence & Clinical Pharmacy 21, no. 4 (1987): 380. http://dx.doi.org/10.1177/106002808702100416.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Costa, Kevin D. "Decellularized Scaffold Hydrogel Materials for MI Treatment." Journal of the American College of Cardiology 67, no. 9 (2016): 1087–90. http://dx.doi.org/10.1016/j.jacc.2016.01.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

EVANS, JEFF. "Bivalirudin, DES Optimal Treatment for Acute MI." Cardiology News 6, no. 11 (2008): 1–4. https://doi.org/10.1016/s1544-8800(08)70411-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Zhang, Wenyuan, Dan Peng, Shiqi Cheng, et al. "Inflammatory Cell-Targeted Delivery Systems for Myocardial Infarction Treatment." Bioengineering 12, no. 2 (2025): 205. https://doi.org/10.3390/bioengineering12020205.

Full text

Abstract:

Myocardial infarction (MI) is a cardiovascular disease (CVD) with high morbidity and mortality worldwide, which is a serious threat to human life and health. Inflammatory and immune responses are initiated immediately after MI, and unbalanced inflammation post-MI can lead to cardiac dysfunction, scarring, and ventricular remodeling, emphasizing the critical need for an effective inflammation-regulating treatment. With the development of novel therapies, the drug delivery system specific to inflammatory cells offers significant potential. In this review, we introduce immune cells and fibroblast

APA, Harvard, Vancouver, ISO, and other styles

28

El-Helou, Viviane, Cindy Proulx, Hugues Gosselin, et al. "Dexamethasone treatment of post-MI rats attenuates sympathetic innervation of the infarct region." Journal of Applied Physiology 104, no. 1 (2008): 150–56. http://dx.doi.org/10.1152/japplphysiol.00663.2007.

Full text

Abstract:

Sympathetic fiber innervation of the damaged region following injury represents a conserved event of wound healing. The present study tested the hypothesis that impaired scar healing in post-myocardial infarction (post-MI) rats was associated with a reduction of sympathetic fibers innervating the infarct region. In 1-wk post-MI rats, neurofilament-M-immunoreactive fibers (1,116 ± 250 μm2/mm2) were detected innervating the infarct region and observed in close proximity to a modest number of endothelial nitric oxide synthase-immunoreactive scar-residing vessels. Dexamethasone (Dex) treatment (6

APA, Harvard, Vancouver, ISO, and other styles

29

Wei, Qidong, Yifei Xiao, Lixin Du, and Ya Li. "Advances in Nanoparticles in the Prevention and Treatment of Myocardial Infarction." Molecules 29, no. 11 (2024): 2415. http://dx.doi.org/10.3390/molecules29112415.

Full text

Abstract:

Myocardial infarction (MI) is one of the most prevalent types of cardiovascular disease. During MI, myocardial cells become ischemic and necrotic due to inadequate blood perfusion, leading to irreversible damage to the heart. Despite the development of therapeutic strategies for the prevention and treatment of MI, their effects are still unsatisfactory. Nanoparticles represent a new strategy for the pre-treatment and treatment of MI, and novel multifunctional nanoparticles with preventive and therapeutic capabilities hold promise for the prevention and treatment of this disease. This review su

APA, Harvard, Vancouver, ISO, and other styles

30

Einstein, Danielle A., and Ross G. Menzies. "Does Magical Thinking Improve Across Treatment For Obsessive–Compulsive Disorder?" Behaviour Change 25, no. 3 (2008): 149–55. http://dx.doi.org/10.1375/bech.25.3.149.

Full text

Abstract:

AbstractThe present study investigated whether MI is a mechanism for change in the treatment of obsessive–compulsive disorder (OCD). The Magical Ideation scale (MI), the Obsessive–Compulsive Inventory — Short Version (OCI-SV) and the Padua Inventory were completed by 34 obsessive–compulsive patients pre- and post cognitive–behavioural treatment. Treatment did not target magical styles of thinking. Significant improvements on all three measures of obsessive–compulsive symptoms were demonstrated by t tests over the course of treatment. Improvement in magical thinking was also shown to be signifi

APA, Harvard, Vancouver, ISO, and other styles

31

Daniëls, Marcel C. G., Rebecca S. Keller, and Pieter P. de Tombe. "Losartan prevents contractile dysfunction in rat myocardium after left ventricular myocardial infarction." American Journal of Physiology-Heart and Circulatory Physiology 281, no. 5 (2001): H2150—H2158. http://dx.doi.org/10.1152/ajpheart.2001.281.5.h2150.

Full text

Abstract:

We studied the effects of chronic losartan (Los) treatment on contractile function of isolated right ventricular (RV) trabeculae from rat hearts 12 wk after left ventricular (LV) myocardial infarction (MI) had been induced by ligation of the left anterior descending artery at 4 wk of age. After recovery, one-half of the animals were started on Los treatment (MI+Los; 30 mg · kg−1 · day−1per os); the remaining animals were not treated (MI group). Rats without infarction or Los treatment served as controls (Con group). MI resulted in increases in LV and RV weight and unstressed LV cavity diameter

APA, Harvard, Vancouver, ISO, and other styles

32

Aliyev, Ramil, and Kamran Musayev. "Modern aspects of surgical treatment of post-infarction ventricular septal defect." Azerbaijan Journal of Cardiovascular Surgery 1, no. 1 (2020): 28. http://dx.doi.org/10.5455/azjcvs.2020.1.1.7.

Full text

Abstract:

Determination of the anatomical location of the ventricular septal defect (VSD), one of the complications that may develop after acute myocardial infarction (MI), affects the surgical intervention and surgical success. Improved surgical techniques and heart protection methods, increased anesthesia and reanimation experience with new prosthetic patches have increased the success of surgical intervention in post-MI VSD. Long-term survivals of patients treated surgically have been reported to be better than those who did not undergo surgery. In autopsy studies, the incidence of VSD after acute my

APA, Harvard, Vancouver, ISO, and other styles

33

Légaré, Jean-Francois, Adam Oxner, Olivier Heimrath, Tanya Myers, and R. William Currie. "Heat shock treatment results in increased recruitment of labeled PMN following myocardial infarction." American Journal of Physiology-Heart and Circulatory Physiology 293, no. 5 (2007): H3210—H3215. http://dx.doi.org/10.1152/ajpheart.00773.2007.

Full text

Abstract:

One of the proposed mechanisms for the myocardial protective effects of heat shock (HS) treatment has been a reduction in the inflammatory response. The objective of the present study was to evaluate the impact of HS treatment in an established model of polymorphonuclear cell (PMN) migration following myocardial infarction (MI). Isolated purified PMNs (10 × 106cells) labeled with51Cr were injected into Lewis rats following a left thoracotomy and ligation of the left anterior descending coronary artery causing MI. Two experimental groups of animals were created: MI group ( n = 11) and HS+MI gro

APA, Harvard, Vancouver, ISO, and other styles

34

Bazazhi, S. G., A. V. Zakharov, O. V. Demikhova, A. A. Polyakov, V. V. Romanov, and A. E. Ergeshov. "TREATMENT EFFECTIVENESS IN PATIENTS WITH TB/HIV CO-INFECTION AND MENTAL ILLNESS." Вестник ЦНИИТ 8, no. 3 (2024): 70–84. http://dx.doi.org/10.57014/2587-6678-2024-8-3-70-84.

Full text

Abstract:

Objective: to evaluate the impact of mental illness (MI) on the effectiveness of TB treatment in TB/HIV co-infected cases. Materials and methods. We carried out a comparative analysis of TB treatment effectiveness in 162 cases: 94 TB/HIV cases with MI and 68 TB/HIV cases without MI. We studied clinical, radiological, and immunological characteristics of cases, drug susceptibility data, the volume of TB treatment, concomitant diseases, and the structure of adverse events.Results. The effectiveness of treatment based on sputum conversion by the end of the inpatient phase was twice lower in MI ca

APA, Harvard, Vancouver, ISO, and other styles

35

DeFilippis, Andrew P., Andrew R. Chapman, Nicholas L. Mills, et al. "Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury." Circulation 140, no. 20 (2019): 1661–78. http://dx.doi.org/10.1161/circulationaha.119.040631.

Full text

Abstract:

Although coronary thrombus overlying a disrupted atherosclerotic plaque has long been considered the hallmark and the primary therapeutic target for acute myocardial infarction (MI), multiple other mechanisms are now known to cause or contribute to MI. It is further recognized that an MI is just one of many types of acute myocardial injury. The Fourth Universal Definition of Myocardial Infarction provides a taxonomy for acute myocardial injury, including 5 subtypes of MI and nonischemic myocardial injury. The diagnosis of MI is reserved for patients with myocardial ischemia as the cause of myo

APA, Harvard, Vancouver, ISO, and other styles

36

Graham, Garth. "Acute Coronary Syndromes in Women: Recent Treatment Trends and Outcomes." Clinical Medicine Insights: Cardiology 10 (January 2016): CMC.S37145. http://dx.doi.org/10.4137/cmc.s37145.

Full text

Abstract:

In the USA and internationally, women experience far-ranging differences with respect to acute coronary syndrome (ACS) and myocardial infarction (MI). Women suffer from more comorbidities than men, such as smoking, obesity, hypertension, diabetes, and poor mental health. They sometimes exhibit atypical MI presentation symptoms and are overall less likely to present with chest pain. Women are more likely than men to encounter delays between the onset of symptoms and arrival at the hospital or to guideline treatment. The use of various surgical and pharmacological treatments, including revascula

APA, Harvard, Vancouver, ISO, and other styles

37

Ishani, Areef, Cynthia Hau, William C. Cushman, et al. "Chlorthalidone vs Hydrochlorothiazide for Hypertension Treatment After Myocardial Infarction or Stroke." JAMA Network Open 7, no. 5 (2024): e2411081. http://dx.doi.org/10.1001/jamanetworkopen.2024.11081.

Full text

Abstract:

ImportancePatients with prior myocardial infarction (MI) or stroke have a greater risk of recurrent cardiovascular (CV) events.ObjectiveTo evaluate the association of chlorthalidone (CTD) vs hydrochlorothiazide (HCTZ) with CV outcomes and noncancer deaths in participants with and without prior MI or stroke.Design, Setting, and ParticipantsThis was a prespecified secondary analysis of the Diuretic Comparison Project (DCP), a pragmatic randomized clinical trial conducted within 72 participating Veterans Affairs health care systems from June 2016 to June 2021, in which patients aged 65 years or o

APA, Harvard, Vancouver, ISO, and other styles

38

Gao, Ling, Lu Wang, Yuhua Wei, et al. "Exosomes secreted by hiPSC-derived cardiac cells improve recovery from myocardial infarction in swine." Science Translational Medicine 12, no. 561 (2020): eaay1318. http://dx.doi.org/10.1126/scitranslmed.aay1318.

Full text

Abstract:

Cell therapy treatment of myocardial infarction (MI) is mediated, in part, by exosomes secreted from transplanted cells. Thus, we compared the efficacy of treatment with a mixture of cardiomyocytes (CMs; 10 million), endothelial cells (ECs; 5 million), and smooth muscle cells (SMCs; 5 million) derived from human induced pluripotent stem cells (hiPSCs), or with exosomes extracted from the three cell types, in pigs after MI. Female pigs received sham surgery; infarction without treatment (MI group); or infarction and treatment with hiPSC-CMs, hiPSC-ECs, and hiPSC-SMCs (MI + Cell group); with hom

APA, Harvard, Vancouver, ISO, and other styles

39

Mavrogeni, S. I., M. Tsirintani, C. Kleanthous, et al. "Supervision of thrombolysis of acute myocardial infarction using telemedicine." Journal of Telemedicine and Telecare 6, no. 1 (2000): 54–58. http://dx.doi.org/10.1258/1357633001933853.

Full text

Abstract:

The treatment of acute myocardial infarction (MI) constitutes a significant problem in remote geographical areas of Greece. Furthermore, thrombolysis, the treatment of choice in the early phase of acute MI, requires the supervision of an expert. We have used thrombolytic treatment, using telemedicine, in remote medical centres. The Onassis Cardiac Surgery Centre was linked to six remote Aegean islands via telemedicine systems which permitted the transmission of 12-lead electrocardiograms (ECGs). The thrombolytic agent anistreplase was administered to patients with acute MI. Supervision, includ

APA, Harvard, Vancouver, ISO, and other styles

40

Sollid, L. M., and K. E. A. Lundin. "Diagnosis and treatment of celiac disease." Mucosal Immunology 2, no. 1 (2008): 3–7. http://dx.doi.org/10.1038/mi.2008.74.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Hanson, Moriah, and Maura Concialdi. "Motor imagery in multiple sclerosis: exploring applications in therapeutic treatment." Journal of Neurophysiology 121, no. 2 (2019): 347–49. http://dx.doi.org/10.1152/jn.00291.2018.

Full text

Abstract:

Motor imagery (MI) is a promising rehabilitation technique that has received significant interest for use in persons with multiple sclerosis (MS). Through alterations in neural networks, MI has the potential to improve measures of walking speed, walking distance, and fatigue in people with MS. Further research is required to assess the validity of MI in conjunction with other therapeutic MS treatments and provide objective outcome measures of motor improvements.

APA, Harvard, Vancouver, ISO, and other styles

42

Ibarra-Lara, Luz, María Sánchez-Aguilar, Elizabeth Soria-Castro, et al. "Clofibrate Treatment Decreases Inflammation and Reverses Myocardial Infarction-Induced Remodelation in a Rodent Experimental Model." Molecules 24, no. 2 (2019): 270. http://dx.doi.org/10.3390/molecules24020270.

Full text

Abstract:

Myocardial infarction (MI) initiates an inflammatory response that promotes both beneficial and deleterious effects. The early response helps the myocardium to remove damaged tissue; however, a prolonged later response brings cardiac remodeling characterized by functional, metabolic, and structural pathological changes. Current pharmacological treatments have failed to reverse ischemic-induced cardiac damage. Therefore, our aim was to study if clofibrate treatment was capable of decreasing inflammation and apoptosis, and reverse ventricular remodeling and MI-induced functional damage. Male Wis

APA, Harvard, Vancouver, ISO, and other styles

43

Lafci Büyükkahraman, Mehtap, Houjia Chen, Benito M. Chen-Charpentier, Jun Liao, and Hristo V. Kojouharov. "A Mathematical Exploration of the Effects of Ischemia-Reperfusion Injury After a Myocardial Infarction." Bioengineering 12, no. 2 (2025): 177. https://doi.org/10.3390/bioengineering12020177.

Full text

Abstract:

Introduction: After myocardial infarction (MI), the heart undergoes necrosis, inflammation, scar formation, and remodeling. While restoring blood flow is crucial, it can cause ischemia-reperfusion (IR) injury, driven by reactive oxygen species (ROSs), which exacerbate cell death and tissue damage. This study introduces a mathematical model capturing key post-MI dynamics, including inflammatory responses, IR injury, cardiac remodeling, and stem cell therapy. The model uses nonlinear ordinary differential equations to simulate these processes under varying conditions, offering a predictive tool

APA, Harvard, Vancouver, ISO, and other styles

44

Arkowitz, Hal, and Henny A. Westra. "Integrating Motivational Interviewing and Cognitive Behavioral Therapy in the Treatment of Depression and Anxiety." Journal of Cognitive Psychotherapy 18, no. 4 (2004): 337–50. http://dx.doi.org/10.1891/jcop.18.4.337.63998.

Full text

Abstract:

Many clients engaging in Cognitive Behavioral Therapy (CBT) for depression and anxiety are ambivalent about change, and about taking necessary actions to bring about change such as exposure or behavioral activation exercises. Given the focus of motivational interviewing (MI) on enhancing readiness for change, it is of great interest to investigate applications of MI to prevalent disorders such as depression and anxiety. After exploring the rationale for integrating MI with CBT for these disorders, we outline unique features of MI that may render it a useful complement to CBT, such as its focus

APA, Harvard, Vancouver, ISO, and other styles

45

Schwenke, Daryl O., Takeshi Tokudome, Ichiro Kishimoto, et al. "Early Ghrelin Treatment after Myocardial Infarction Prevents an Increase in Cardiac Sympathetic Tone and Reduces Mortality." Endocrinology 149, no. 10 (2008): 5172–76. http://dx.doi.org/10.1210/en.2008-0472.

Full text

Abstract:

Acute myocardial infarction (MI) initiates an increase in cardiac sympathetic nerve activity (CSNA), which ultimately exacerbates chronic cardiac dysfunction. Ghrelin (Ghr), a GH-releasing peptide, is an effective treatment for improving cardiac function in chronic heart failure. Ghr also suppresses renal sympathetic nerve activity (SNA) and, therefore, may have important therapeutic benefits in the early stages of acute MI: by reducing CSNA. In this study we hypothesized that early Ghr administration may prevent an increase in CSNA in the acute phase after MI. CSNA was continuously recorded i

APA, Harvard, Vancouver, ISO, and other styles

46

Tsverava, Lia, Manana Kandashvili, Giorgi Margvelani, et al. "Long-Term Effects of Myoinositol on Behavioural Seizures and Biochemical Changes Evoked by Kainic Acid Induced Epileptogenesis." BioMed Research International 2019 (February 28, 2019): 1–14. http://dx.doi.org/10.1155/2019/4518160.

Full text

Abstract:

Epilepsy is one of the most devastating neurological diseases and despite significant efforts there is no cure available. Occurrence of spontaneous seizures in epilepsy is preceded by numerous functional and structural pathophysiological reorganizations in the brain—a process called epileptogenesis. Treatment strategies targeting this process may be efficient for preventing spontaneous recurrent seizures (SRS) in epilepsy, or for modification of disease progression. We have previously shown that (i) myoinositol (MI) pretreatment significantly decreases severity of acute seizures (status epilep

APA, Harvard, Vancouver, ISO, and other styles

47

Zalewski, Jaroslaw, Karol Nowak, Patrycja Furczynska, and Magdalena Zalewska. "Complicating Acute Myocardial Infarction. Current Status and Unresolved Targets for Subsequent Research." Journal of Clinical Medicine 10, no. 24 (2021): 5904. http://dx.doi.org/10.3390/jcm10245904.

Full text

Abstract:

Mechanical reperfusion with primary angioplasty, as the treatment of choice in acute myocardial infarction (MI), is associated not only with a high percentage of full epicardial and tissue reperfusion but also with a very good immediate and long-term clinical outcome. However, the Achilles heel of MI treatment is its ensemble of complications, such as cardiogenic shock due to severe systolic and/or diastolic dysfunction or MI mechanical complications, including perforation of the left ventricular free wall, papillary muscle rupture with acute mitral regurgitation and ventricular septal rupture

APA, Harvard, Vancouver, ISO, and other styles

48

Smitley, D. R., and T. W. Davis. "Scale Control on Taxus, Ottawa County, MI, 1994." Arthropod Management Tests 20, no. 1 (1995): 306. http://dx.doi.org/10.1093/amt/20.1.306a.

Full text

Abstract:

Abstract Each treatment was replicated 6 times. A replicate was a plot of six 5-yrold (20-inch-high) Taxus shrubs. The field was located at Zelenka’s Evergreen Nursery in Ottawa Co. Precount samples were taken on 6 Sep by clipping two 5-inch-long twigs from each bush (one from the top half of the shrub and one from the bottom half) to make a total of 12 twigs per replicate. The twigs were taken back to the lab to be examined under a dissecting microscope. The Marathon treatment was applied on 6 Sep as a banded treatment. A garden hoe was used to incorporate the material. All other treatments w

APA, Harvard, Vancouver, ISO, and other styles

49

Pkhaladze, Lali, Ludmila Barbakadze, and Nana Kvashilava. "Myo-Inositol in the Treatment of Teenagers Affected by PCOS." International Journal of Endocrinology 2016 (2016): 1–6. http://dx.doi.org/10.1155/2016/1473612.

Full text

Abstract:

Objective. To compare the effectiveness of myo-inositol (MI) and oral contraceptive pills (OCPs) in monotherapy and MI in combination with OCPs in the treatment of teenagers affected by polycystic ovary syndrome (PCOS).Methods. 61 adolescent girls aged 13–19 years, with PCOS, were involved in the prospective, open-label study. Patients were randomized into three groups: I group, 20 patients receiving drospirenone 3 mg/ethinyl estradiol 30 μg; II group, 20 patients receiving 4 g myo-inositol plus 400 mg folic acid; III group, 21 patients receiving both medications.Results. After receiving MI si

APA, Harvard, Vancouver, ISO, and other styles

50

Rosamond, Wayne D., Michael D. Sullivan, Lloyd E. Chambless, Chin-Hua Wang, Lawton S. Cooper, and Aaron R. Folsom. "Survival after Treatment during Hospitalization for Acute Myocardial Infarction:." Circulation 103, suppl_1 (2001): 1346. http://dx.doi.org/10.1161/circ.103.suppl_1.9999-10.

Full text

Abstract:

0010 Background: The wealth of data from clinical trials has done as much to diversify standard therapy for acute myocardial infarction (MI) as it has to define it. To better characterize the use of treatments during hospitalization for MI in clinical practice, we analyzed one-year post MI survival in relation to common treatments in the Atherosclerosis Risk in Communities (ARIC) Study. Methods: Between 1987 and 1996 potential cases of MI among men and women, ages 35-74 were identified through hospital surveillance in Forsyth Co. NC, Jackson, MS, Minneapolis, MN, and Washington Co. MD. Diagnos

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!